Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04491604
Brief Title: The Objective of This Study is to Compare the Efficacy and Safety of Beremagene Geperpavec (B-VEC) Topical Gel With That of Placebo for the Treatment of Dystrophic Epidermolysis Bullosa (DEB).

First Submitted : July 22, 2020
First Submitted that Met QC Criteria : July 27, 2020
First Posted : July 29, 2020

Last Update Submitted that Met QC Criteria : July 27, 2020
Last Update Posted : July 29, 2020